Aug 2026· Analytical Chemistry· Vol 98 34, pp.
24761-24774
· 0 citations· 70 references
Medicine
TL;DR
CD-nMS is established, alone or in combination with SLOMO, as a broadly applicable assay for quantitative characterization of complex biomolecular interactions across soluble, glycosylated, and membrane-associated systems.
Abstract
Native mass spectrometry (nMS) is a powerful label-free method for detecting biomolecular complexes, resolving stoichiometry, and quantifying affinity (Kd). However, signal overlap in heterogeneous systems often limits its accuracy. Charge detection (CD)-nMS, which independently measures the mass-to-charge ratio and charge of individual ions, overcomes this challenge, enabling quantitative analysis of polydisperse and high molecular weight complexes with unresolved charge states. Here, we systematically validate CD-nMS for precise Kd determination using soluble protein-ligand complexes of known Kd and extend its application to quantify glycan ligand binding by a highly glycosylated immune lectin. We then demonstrate the implementation of slow mixing mode (SLOMO), a time-resolved mixing method that corrects for nonuniform response factors of interacting species, using CD-nMS to enable robust quantification of protein-protein interactions. Finally, we apply SLOMO-CD-nMS to directly detect and quantify bacterial toxin binding to glycolipids embedded in membrane-like assemblies, a capability not accessible with conventional nMS. These measurements uncovered previously unrecognized assembly pathways and demonstrate, for the first time, that SLOMO-CD-nMS can resolve and quantify multivalent lectin engagement with glycolipids in a native-like membrane context. Collectively, these results establish CD-nMS, alone or in combination with SLOMO, as a broadly applicable assay for quantitative characterization of complex biomolecular interactions across soluble, glycosylated, and membrane-associated systems.
Together, these tools offer complementary insights into HOS that are reshaping structural biology, biopharmaceutical development and mechanistic studies.
D. Herath, Kaitlyn N. Walls, Ashlyn N. Dollar et al.· In Analysis· 0 citations
AEMS coupled to a high-resolution QTOF mass spectrometer as a high-throughput platform for nMS screening is demonstrated and acoustic ejection nMS is a practical high-throughput screening platform that simultaneously delivers direct molecular information on protein-ligand binding, binding stoichiometry, and protein oli...
Kerri Grove, Chang Liu, Thomas R. Covey et al.· SLAS discovery : advancing l...· 0 citations
The usefulness of microfluidic capillary electrophoresis-mass spectrometry (MCE-MS) for rapid purity and proteoform profiling of BsAb samples is demonstrated and the developed MCE-MS workflow exhibits great potential to accelerate and enhance decision-making during BsAb development and production.
Ruben Cageling, Karin Lubbers-Geuijen, G. Somsen et al.· Analytical and Bioanalytical...· 0 citations
This strategy enables sensitive and physiologically relevant identification of protein complexes, offering a reliable approach for characterizing the composition of potential protein assemblies within specific biological systems.
Protein-protein interactions (PPIs) underpin nearly all cellular processes; therefore, mapping PPI and protein-protein association networks is critical for understanding how biological systems function in health and disease. However, many functionally relevant PPIs are transient and mediated by weak affinity interactio...
Hugo Gizardin-Fredon, Salvatore Terrosu, Simon Pichard et al.· bioRxiv· 0 citations
The results demonstrate the feasibility of directly detecting an endogenous high-molecular-weight protein complex and its cofactor-binding states from crude human cultured cell lysates, providing a basis for extending this approach to other endogenous protein assemblies and future single-cell native MS analyses.
Michiko Tajiri, Yusuke Tateishi, Qiu-Yi Wang et al.· Mass Spectrometry· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.